News

The Sjögren’s Foundation has developed clinical practice guidelines for healthcare providers to improve the diagnosis, evaluation, and care of Sjögren’s syndrome patients with lung manifestations. The guidelines, which include 52 recommendations for Sjögren’s evaluation and…

A variant of the LILRA3 gene may be associated with greater lymphoma susceptibility in a group of Sjögren’s syndrome patients with disease onset prior to age 40, a study reports. The variant could be a potential biomarker of…

In observance of Sjögren’s Awareness Month in April, the Sjögren’s Foundation is inviting individuals with to share their stories to help raise awareness about this complex condition. This year’s theme, “Coming Together to Conquer Sjögren’s,” will showcase the many Faces of Sjögren’s and illustrate…

People with primary Sjögren’s syndrome are six times more likely to be deficient in vitamin B12, a study found, supporting the need for screening and treating vitamin B12 deficiency in these patients. The study “Association of Primary Sjögren’s Syndrome and Vitamin B12 Deficiency: A…

Production of Myd88, a protein associated with autoimmune diseases, in distinct types of cells mediates different characteristics of primary Sjögren’s syndrome, a study in mouse models of this disease reported.  These findings have implications for targeted therapies, as Myd88 activation may be protective in certain cell types and organs,…

Most patients with primary Sjögren’s syndrome experience gastrointestinal problems but have no recommended treatments available due to lack of information about the underlying causes, a pilot study reports. Future studies will be needed to identify these causes and to explore the possible relationship between these symptoms and other conditions,…

The amount of a protein called ATG5 in tears may pinpoint people whose dry eye symptoms are related to Sjögren’s syndrome with greater accuracy than standard diagnostic tests, a study has found. However, ATG5’s potential as a biomarker of the disorder should be investigated further, the researchers said. The…

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review to an application for Esbriet (pirfenidone) as a treatment for unclassifiable interstitial lung disease (UILD). The supplemental new drug application was submitted by Genentech, Esbriet’s developer and a member of the Roche Group, based on…

Tocilizumab, a medicine approved for certain types of arthritis, may be a safe and effective approach for treating severe respiratory distress associated with COVID-19 in people with autoimmune conditions, the case of an elderly Sjögren’s syndrome patient suggests. The report, “…